Prevnar family (pneumococcal 13-valent conjugate vaccine) Disease area(s): Vaccines/infectious diseases Manufacturer(s): Pfizer 2024 Sales (USD): $6.41 billion Why it sold so well: In 2024, Pfizers Prevnar family of pneumococcal vaccines generated $6.4 billion in global revenue, accounting for 10% of the companys total revenue and ranking as its second-highest-selling product after Eliquis
Although small amounts of unconverted Cyanocobalamin will remain in the system, this is typically nothing more than is left behind from the consumption of common supplements and foodstuffs containing B vitamins
Louis Health Care System, told CNN
The One-way ANOVA test was performed to identify the correlation between the dependent variables
Educating patients on these aspects significantly contributes to improving adherence to therapeutic protocols, thus maximizing the benefits deriving from oral semaglutide
On May 22, the House passed a reconciliation bill, the One Big Beautiful Bill Act, which would partially pay to extend expiring tax cuts by cutting Medicaid
